To directly validate that MALAT1 induces TMZ resistance in GBM cells, we treated parental U87 and U251 cells with a concentration gradient from 0–3200 μM TMZ after being transfected with pMALAT1 or negative control. This evidence concerns the gene MALAT1 and glioblastoma.